Alpha Wave Ventures II sold over 3.5 crore shares of Pine Labs in a block deal, raising around ₹550 crore and trimming its holding in the fintech company to a negligible level.
- Alpha Wave sold 3.54 Cr Pine Labs shares at ₹155.10 each
- Stake sale raised ₹550 crore, reducing holding to just 4.9 lakh shares
- Major buyers included ICICI Prudential, Societe Generale, and Goldman Sachs
What happened
Alpha Wave Ventures II conducted a major block deal sale of 3.54 crore shares of Pine Labs, fetching an average price of ₹155.10 per share. This represented a discount of about 4.4% to the closing market price and resulted in net proceeds of ₹550 crore. Prior to this sale, Alpha Wave held approximately 3.59 crore shares, and the transaction drastically reduced their holding to just under 5 lakh shares.
Several prominent institutional investors participated on the buying side, with ICICI Prudential Life Insurance acquiring over 1 crore shares, followed by Societe Generale and Goldman Sachs picking up sizable stakes. Domestic mutual funds including JM Financial and Edelweiss also increased their Pine Labs exposure through this block deal.
Why it matters
This sale marks another step in Alpha Wave’s broader move to pare down its investments, following recent exits and partial liquidations in companies like Lenskart, Aye Finance, and Delhivery. The firm has been systematically reducing stakes across its portfolio, signaling possible portfolio reallocation or capital redeployment plans.
Pine Labs itself remains an attractive investment given its improving financial metrics. The company posted a net profit of ₹19.6 crore in Q1 FY27, a more than fourfold increase year-over-year, alongside 20% revenue growth. The improved profitability and revenue trends highlight Pine Labs' strengthening market position amid these share transfers.
What to watch next
Market watchers should monitor how remaining institutional investors adjust their holdings in Pine Labs and whether Alpha Wave fully exits its position soon. With over 93 crore shares unlocked for trading since May due to the post-IPO lock-in expiry, liquidity and block deal activity may continue to influence the stock price and ownership structure.
Additionally, investors will keep an eye on Pine Labs’ upcoming financial performance and strategic moves, as it builds on recent momentum. How the company balances growth and profitability will be key, especially as it navigates increased institutional interest and potential shareholder changes.